Register

I agree with the Privacy Policy

Los Angeles Times

Medical giant Medtronic to buy rival Covidien for $42.9 billion

June 15, 2014

Because both companies already are giants in the medical-devices market, the merger should allow for more robust research and development and more comprehensive health-monitoring capabilities, said Harry Wang, a health industry analyst at product research firm Parks Associates.

The medical devices industry has been plagued by slow innovation, but the merger should advance the market, Wang said.

“By buying up this company and consolidating R&D spending, they have a better chance of getting their products to market,” he said. “Over the long term, if R&D is spent wisely and effectively, you will see more cost-effective products for consumers.”

From the article, "Medical giant Medtronic to buy rival Covidien for $42.9 billion" by Javier Panzar.

Previously In The News

Nielsen to track video game use

"It's not the old media world anymore," said Michael Cai, analyst with Parks Associates in Dallas, who estimates that spending on advertising within games will grow to more than $800 million in 201...

Make way for the iPad

Until recently, the price tag for home automation systems ranged from $30,000 to $50,000 and kept the industry stagnant, says Kurt Scherf, a market researcher at Dallas-based Parks Associates, whic...

Software Provides DVDs on Demand

With the software, retailers could download specific films requested by customers, who can place their orders online. The DVDs would then be delivered by mail or picked up at in-store kiosks simila...

IPO May Help Shutterfly Compete

Online photo companies have a high level of customer loyalty, said Harry Wang, a research analyst at Parks Associates. After a customer accumulates a lot of pictures on an online photography site,...

‹
1
2
3
4
5
6
7
8
9
10
›